Ilika Plc Appoint Dr. Monika Biddulph with 20+ years of ARM IP licensing experience

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery company, announced today the appointment of Dr. Monika Biddulph as a Non- Executive Director.

Until August 2018, Monika was a member of the Senior Leadership Team IP Product Groups at ARM Holdings plc (‘ARM’), responsible for driving the execution of the product roadmaps across all lines of business and central engineering. In over twenty years at ARM, Monika held various General Manager and licensing roles in the business. She was previously NED at Linaro Limited, an open source software organisation. Monika holds a PhD in Physics from the ETH Zurich.

Keith Jackson, Ilika plc Chairman stated:

“I am excited to have Monika joining our Board bringing over twenty years of ARM IP licensing experience and a complementary broad set of commercial and technical skills to Ilika. This is an opportune time for Monika’s appointment as the Company moves forward with its commercialisation of IP coupled with negotiating licencing terms with potential OEMs.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Search

Search